Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury
about
The Role of Ectonucleotidases CD39 and CD73 and Adenosine Signaling in Solid Organ TransplantationThe CD39-adenosinergic axis in the pathogenesis of immune and nonimmune diabetesAttenuating myocardial ischemia by targeting A2B adenosine receptorsMolecular mechanisms of ischemic preconditioning in the kidneyAdenosine receptors and the kidneyThe reno-vascular A2B adenosine receptor protects the kidney from ischemiaCharacterization of a monoclonal antibody as the first specific inhibitor of human NTP diphosphohydrolase-3 : partial characterization of the inhibitory epitope and potential applicationsAdenosine receptors as drug targets--what are the challenges?Targeting of adenosine receptors in ischemia-reperfusion injury.Cytoprotective effects of adenosine and inosine in an in vitro model of acute tubular necrosis.Hypoxia inducible factor (HIF)-1 coordinates induction of Toll-like receptors TLR2 and TLR6 during hypoxiaATP release from vascular endothelia occurs across Cx43 hemichannels and is attenuated during hypoxia.Oxygen-independent stabilization of hypoxia inducible factor (HIF)-1 during RSV infection.Adenosine: an old drug newly discovered.Cellular mechanisms of tissue fibrosis. 6. Purinergic signaling and response in fibroblasts and tissue fibrosisSP1-dependent induction of CD39 facilitates hepatic ischemic preconditioning.Targeting the A2B adenosine receptor during gastrointestinal ischemia and inflammationComplete deletion of Cd39 is atheroprotective in apolipoprotein E-deficient micePartial netrin-1 deficiency aggravates acute kidney injuryCystic fibrosis remodels the regulation of purinergic signaling by NTPDase1 (CD39) and NTPDase3Purinergic signaling during inflammation.Extracellular nucleotide and nucleoside signaling in vascular and blood diseaseThe guanosine-adenosine interaction exists in vivo.The resurgence of A2B adenosine receptor signalingBiological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states.Selective induction of endothelial P2Y6 nucleotide receptor promotes vascular inflammation.Adenosine receptors and renal ischaemia reperfusion injury.Targeting Hypoxia-induced Inflammation.CD39 improves survival in microbial sepsis by attenuating systemic inflammation2'-AMP and 3'-AMP inhibit proliferation of preglomerular vascular smooth muscle cells and glomerular mesangial cells via A2B receptorsExtracellular adenosine: a safety signal that dampens hypoxia-induced inflammation during ischemiaUse of a hanging weight system for coronary artery occlusion in mice.Use of a hanging-weight system for isolated renal artery occlusionPressure controlled ventilation to induce acute lung injury in miceLiver damage and systemic inflammatory responses are exacerbated by the genetic deletion of CD39 in total hepatic ischemiaTransgenic over expression of ectonucleotide triphosphate diphosphohydrolase-1 protects against murine myocardial ischemic injury.The hypoxia-inflammation link and potential drug targets.Equilibrative nucleoside transporter 1 (ENT1) regulates postischemic blood flow during acute kidney injury in miceAdenosine and protection from acute kidney injury.Extracellular ATP protects against sepsis through macrophage P2X7 purinergic receptors by enhancing intracellular bacterial killing
P2860
Q21131166-FED56F7E-A775-4905-90D9-63EC3155B7ECQ26825668-04CEA920-83F6-43B2-A811-9A1610C3A2CDQ27006863-39C9C80D-77F1-4C03-8140-1ED17A1B470FQ28080772-D9CC8C50-0C2D-4D80-804F-C057576DABF6Q28253255-1C21E5EC-3894-4D8D-86F8-0D0E72AA4C2BQ28473410-6839180D-4D6C-4437-95A2-400B2BB9E531Q28817851-321419F2-05CC-4D6F-9CBD-3CC4B74B5182Q29346491-4464C97E-D58A-4ABB-B4BF-BA9A48191EC8Q30429069-585E192A-EBE8-4C70-B00C-A39D7846B60AQ30881980-AA449371-82DC-42A3-9B87-3EA569B319E0Q33312383-BE8099A2-522D-43D6-8846-70589F0D0A52Q33356018-1FC09F6B-F9E3-42C4-9639-7F2108CC772FQ33374284-7F57720B-BFEC-45CF-9AFD-D2F8D00D324BQ33555006-3CF42765-30AE-43DB-84FC-9DF2DC58B9F0Q33569405-3157E709-C929-4424-8750-CFD467DF765EQ33756417-3D6E65E2-6D4F-4BCE-A31A-10A78D59538AQ33830064-C434E823-CA02-4B3C-851F-B70E83D23DE5Q33867669-098694F2-1EBE-4BF3-8DC7-B8598C37EB86Q33916670-7652FCB0-8C22-4D4B-B4CA-03F236E35A9FQ33916983-F4E39EB9-F4D5-4523-AD74-8FC3495F7036Q34034751-DD0BF650-E9DE-46F9-A5E8-65225E6238CFQ34047834-D6BFD2F7-07DD-448E-A09A-E4F07D272B24Q34125107-0AB67665-588C-4117-BA77-7DC29C8296D1Q34307284-071887F7-C7D2-4FD0-960F-9B605171469FQ34703746-A435BD52-D934-4CA5-B7FA-082E3808574DQ34707637-2347A479-E508-4577-BC94-790CDC98FDF7Q34735024-1D5DCFA5-E74F-452F-95B8-6AD882FE011AQ34780737-5CF7810D-3AA3-431C-81A7-BF88EEECF798Q34847971-74D882AB-AC55-487E-96C0-45D1BD770B0DQ34868248-C110DEAA-2A6B-4A70-B51D-502FD9231C00Q35193886-32DF63A2-9721-4FE2-88C1-E43BE74C05EFQ35203103-83EDE179-09C8-4E6B-8D4E-DBBF6165458DQ35379329-11DA5A02-2C4F-4C66-8C3A-6A7FE14846C0Q35392090-528D5B77-909F-43E3-8B69-33C91C1159D0Q35574518-C20949D8-075F-4B94-8CF1-84D3CDB4A3A7Q35632965-ED8BF511-2581-493C-9492-5424AB41B5BBQ35676172-1A677A7B-0F9A-4EFE-9E66-B9E282789B41Q35698980-9E6D2995-341C-46FB-A0B3-5206D7FD5BC5Q35755490-EF8A6E91-4979-444F-86AC-430366A8708BQ35998001-6AFF9186-3C79-435C-B98B-2339A3216159
P2860
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury
description
im September 2007 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 2007
@uk
name
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury
@en
Contribution of E-NTPDase1
@nl
type
label
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury
@en
Contribution of E-NTPDase1
@nl
prefLabel
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury
@en
Contribution of E-NTPDase1
@nl
P2093
P356
P1433
P1476
Contribution of E-NTPDase1 (CD39) to renal protection from ischemia-reperfusion injury
@en
P2093
Christa E. Müller
Dan Yang Huang
Holger K. Eltzschig
Karin Klingel
Marina Hermes
Simon C. Robson
Tobias Eckle
P304
P356
10.1096/FJ.06-7947COM
P407
P577
2007-09-01T00:00:00Z